BioNTech SE (XTER:22UA)
€ 104.5 5.1 (5.13%) Market Cap: 24.57 Bil Enterprise Value: 8.11 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 67/100

Q3 2021 BioNTech SE Earnings Call Transcript

Nov 09, 2021 / 01:00PM GMT
Release Date Price: €202.3 (-0.25%)
Operator

Welcome to BioNTech Third Quarter 2021 Update Call. (Operator Instructions) I must advise you this call is being recorded today, Tuesday, the 9th of November 2021. And I would now like to hand the meeting over to the Vice President, Investor Relations and Strategy, Sylke Maas. Please go ahead.

Sylke Maas
BioNTech SE - VP of IR and Business Strategy

Good morning and good afternoon. Thank you for joining us today to review BioNTech's Third Quarter 2021 Operational Progress and Financial Results. Before we start, we quote you to view the slides for this webcast as well as the operational and financial results' press release issued this morning, both of which are accessible on our website in our investor section.

As shown on Slide 2, during today's presentation, we will be making several forward-looking statements. These forward-looking statements include, but are not limited to, our current estimated COVID-19 vaccine revenue based on current contracted supply orders particularly for those figures that are derived from preliminary estimates provided by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot